FMA
GHDX

FNY Managed Accounts’s Genomic Health, Inc. GHDX Stock Holding History

FNY Managed Accounts’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-100
Closed -$2.78K – 634
2015
Q2 		$2.78K Buy
+100
New +$2.82K ﹤0.01% 393

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FNY Managed Accounts's GHDX Position: Q3 2015 in Review

FNY Managed Accounts sold out of Genomic Health, Inc. (GHDX) in Q3 2015, closing a stake of 100 shares — an estimated $2.78K sold.

FNY Managed Accounts first reported a position in GHDX in Q2 2015 and held it in 1 quarter. The position peaked at $2.78K in Q2 2015. 117 funds tracked by Wall St. Rank hold GHDX as of Q3 2015.

  • FNY Managed Accounts reported no remaining Genomic Health, Inc. position as of Q3 2015 after selling out during the quarter.
  • FNY Managed Accounts sold 100 Genomic Health, Inc. shares in Q3 2015, an estimated $2.78K.
  • FNY Managed Accounts first reported a position in Genomic Health, Inc. in Q2 2015 and held it in 1 quarter.
  • FNY Managed Accounts's Genomic Health, Inc. position peaked at $2.78K in Q2 2015.
  • 117 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2015.

Based on FNY Managed Accounts's 13F filing for Q3 2015, filed 27 Oct 2015.